ReP USP - Resultado da busca

Artigo de periodico
Development and validation of a UV spectrophotometric method for biowaiver studies in pyrazinamide tablets (2024)
Bobadilla, Vanessa Saldaña; Villanueva, Cintia P. Barreto; Gasco, Frizzi J. Ganoza; Chauca, Enma Perez; Aquiño, Olga E. Caballero; Rodriguez, Ana E. Mantilla; Plasencia, Pedro Marcelo Alva; Aurora-Prado, Maria Segunda
Fonte: Journal of Pharmacy and Pharmacognosy Research. Unidade: FCF
Assuntos: ESPECTROFOTOMETRIA, BIOEQUIVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOBADILLA, Vanessa Saldaña et al. Development and validation of a UV spectrophotometric method for biowaiver studies in pyrazinamide tablets. Journal of Pharmacy and Pharmacognosy Research, v. 12, n. 3, p. 539-547, 2024Tradução . . Disponível em: https://dx.doi.org/10.56499/jppres23.1846_12.3.539. Acesso em: 13 nov. 2024.
APA
Bobadilla, V. S., Villanueva, C. P. B., Gasco, F. J. G., Chauca, E. P., Aquiño, O. E. C., Rodriguez, A. E. M., et al. (2024). Development and validation of a UV spectrophotometric method for biowaiver studies in pyrazinamide tablets. Journal of Pharmacy and Pharmacognosy Research, 12( 3), 539-547. doi:10.56499/jppres23.1846_12.3.539
NLM
Bobadilla VS, Villanueva CPB, Gasco FJG, Chauca EP, Aquiño OEC, Rodriguez AEM, Plasencia PMA, Aurora-Prado MS. Development and validation of a UV spectrophotometric method for biowaiver studies in pyrazinamide tablets [Internet]. Journal of Pharmacy and Pharmacognosy Research. 2024 ; 12( 3): 539-547.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.56499/jppres23.1846_12.3.539
Vancouver
Bobadilla VS, Villanueva CPB, Gasco FJG, Chauca EP, Aquiño OEC, Rodriguez AEM, Plasencia PMA, Aurora-Prado MS. Development and validation of a UV spectrophotometric method for biowaiver studies in pyrazinamide tablets [Internet]. Journal of Pharmacy and Pharmacognosy Research. 2024 ; 12( 3): 539-547.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.56499/jppres23.1846_12.3.539
Artigo de periodico
Development of extended-release formulations containing cyclobenzaprine based on physiologically based biopharmaceutics modeling and bioequivalence safe space (2023)
Santos, Everton Miranda dos; Ferraz, Humberto Gomes ; Issa, Michele Georges ; Duque, Marcelo Dutra
Fonte: Journal of Pharmaceutical Sciences. Unidade: FCF
Assuntos: MEDICAMENTO, BIOEQUIVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Everton Miranda dos et al. Development of extended-release formulations containing cyclobenzaprine based on physiologically based biopharmaceutics modeling and bioequivalence safe space. Journal of Pharmaceutical Sciences, v. 112, n. 12, p. 3131-3140, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.xphs.2023.07.012. Acesso em: 13 nov. 2024.
APA
Santos, E. M. dos, Ferraz, H. G., Issa, M. G., & Duque, M. D. (2023). Development of extended-release formulations containing cyclobenzaprine based on physiologically based biopharmaceutics modeling and bioequivalence safe space. Journal of Pharmaceutical Sciences, 112( 12), 3131-3140. doi:10.1016/j.xphs.2023.07.012
NLM
Santos EM dos, Ferraz HG, Issa MG, Duque MD. Development of extended-release formulations containing cyclobenzaprine based on physiologically based biopharmaceutics modeling and bioequivalence safe space [Internet]. Journal of Pharmaceutical Sciences. 2023 ; 112( 12): 3131-3140.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.xphs.2023.07.012
Vancouver
Santos EM dos, Ferraz HG, Issa MG, Duque MD. Development of extended-release formulations containing cyclobenzaprine based on physiologically based biopharmaceutics modeling and bioequivalence safe space [Internet]. Journal of Pharmaceutical Sciences. 2023 ; 112( 12): 3131-3140.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.xphs.2023.07.012
Artigo de periodico
Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets (2023)
Carapeto, Gustavo Vaiano ; Duque, Marcelo Dutra ; Issa, Michele Georges ; Ferraz, Humberto Gomes
Fonte: Pharmaceutics. Unidade: FCF
Assuntos: MEDICAMENTO GENÉRICO, BIOEQUIVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARAPETO, Gustavo Vaiano et al. Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets. Pharmaceutics, v. 15, p. 1-14 art. 1544, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15051544. Acesso em: 13 nov. 2024.
APA
Carapeto, G. V., Duque, M. D., Issa, M. G., & Ferraz, H. G. (2023). Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets. Pharmaceutics, 15, 1-14 art. 1544. doi:10.3390/pharmaceutics15051544
NLM
Carapeto GV, Duque MD, Issa MG, Ferraz HG. Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets [Internet]. Pharmaceutics. 2023 ; 15 1-14 art. 1544.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3390/pharmaceutics15051544
Vancouver
Carapeto GV, Duque MD, Issa MG, Ferraz HG. Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets [Internet]. Pharmaceutics. 2023 ; 15 1-14 art. 1544.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3390/pharmaceutics15051544
Artigo de periodico
Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling (2022)
Issa, Michele Georges ; Souza, Natalia Vieira de; Jou, Bruna Wenyi Chuang; Duque, Marcelo Dutra ; Ferraz, Humberto Gomes
Fonte: Pharmaceutics. Unidade: FCF
Assuntos: INDÚSTRIA FARMACÊUTICA, MEDICAMENTO, BIOEQUIVALÊNCIA, FORMAS FARMACÊUTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ISSA, Michele Georges et al. Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling. Pharmaceutics, v. 14, p. 1-21 art. 892, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14050892. Acesso em: 13 nov. 2024.
APA
Issa, M. G., Souza, N. V. de, Jou, B. W. C., Duque, M. D., & Ferraz, H. G. (2022). Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling. Pharmaceutics, 14, 1-21 art. 892. doi:10.3390/pharmaceutics14050892
NLM
Issa MG, Souza NV de, Jou BWC, Duque MD, Ferraz HG. Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling [Internet]. Pharmaceutics. 2022 ; 14 1-21 art. 892.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3390/pharmaceutics14050892
Vancouver
Issa MG, Souza NV de, Jou BWC, Duque MD, Ferraz HG. Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling [Internet]. Pharmaceutics. 2022 ; 14 1-21 art. 892.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3390/pharmaceutics14050892
Artigo de periodico
A BCS-based biowaiver approach using biphasic dissolution test (2021)
Silva, Daniela Amaral; Melo, Katherine Jasmine Curo; Davies, Neal M; Bou-Chacra, Nadia Araci ; Ferraz, Humberto Gomes ; Löbenberg, Raimar
Fonte: Dissolution Technology. Unidade: FCF
Assuntos: BIOEQUIVALÊNCIA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. A BCS-based biowaiver approach using biphasic dissolution test. Dissolution Technology, v. 28, n. 4, p. 40-48, 2021Tradução . . Disponível em: https://doi.org/10.14227/DT280421P40. Acesso em: 13 nov. 2024.
APA
Silva, D. A., Melo, K. J. C., Davies, N. M., Bou-Chacra, N. A., Ferraz, H. G., & Löbenberg, R. (2021). A BCS-based biowaiver approach using biphasic dissolution test. Dissolution Technology, 28( 4), 40-48. doi:10.14227/DT280421P40
NLM
Silva DA, Melo KJC, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. A BCS-based biowaiver approach using biphasic dissolution test [Internet]. Dissolution Technology. 2021 ; 28( 4): 40-48.[citado 2024 nov. 13 ] Available from: https://doi.org/10.14227/DT280421P40
Vancouver
Silva DA, Melo KJC, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. A BCS-based biowaiver approach using biphasic dissolution test [Internet]. Dissolution Technology. 2021 ; 28( 4): 40-48.[citado 2024 nov. 13 ] Available from: https://doi.org/10.14227/DT280421P40
Artigo de periodico
Interchangeability of drugs in Peru: Current outlook and future perspectives (2021)
Chauca, Enma Perez ; Ferraz, Humberto Gomes
Fonte: Revista Peruana de Medicina Experimental y Salud Pública. Unidade: FCF
Assuntos: MEDICAMENTO GENÉRICO, BIOEQUIVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAUCA, Enma Perez e FERRAZ, Humberto Gomes. Interchangeability of drugs in Peru: Current outlook and future perspectives. Revista Peruana de Medicina Experimental y Salud Pública, v. 38, n. 2, p. 337-344, 2021Tradução . . Disponível em: https://doi.org/10.17843/rpmesp.2021.382.7322. Acesso em: 13 nov. 2024.
APA
Chauca, E. P., & Ferraz, H. G. (2021). Interchangeability of drugs in Peru: Current outlook and future perspectives. Revista Peruana de Medicina Experimental y Salud Pública, 38( 2), 337-344. doi:10.17843/rpmesp.2021.382.7322
NLM
Chauca EP, Ferraz HG. Interchangeability of drugs in Peru: Current outlook and future perspectives [Internet]. Revista Peruana de Medicina Experimental y Salud Pública. 2021 ; 38( 2): 337-344.[citado 2024 nov. 13 ] Available from: https://doi.org/10.17843/rpmesp.2021.382.7322
Vancouver
Chauca EP, Ferraz HG. Interchangeability of drugs in Peru: Current outlook and future perspectives [Internet]. Revista Peruana de Medicina Experimental y Salud Pública. 2021 ; 38( 2): 337-344.[citado 2024 nov. 13 ] Available from: https://doi.org/10.17843/rpmesp.2021.382.7322
Artigo de periodico
Risk of false pharmaceutical equivalence (non-equivalence) decisions due to measurement uncertainty (2021)
Bertanha, Maria Luiza de Godoy; Lourenço, Felipe Rebello
Fonte: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF
Assuntos: MEDICAMENTO, MEDIÇÃO DE RISCO, BIOEQUIVALÊNCIA, QUALIDADE DOS MEDICAMENTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERTANHA, Maria Luiza de Godoy e LOURENÇO, Felipe Rebello. Risk of false pharmaceutical equivalence (non-equivalence) decisions due to measurement uncertainty. Journal of Pharmaceutical and Biomedical Analysis, v. 204, p. 1-9 art. 114269, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2021.114269. Acesso em: 13 nov. 2024.
APA
Bertanha, M. L. de G., & Lourenço, F. R. (2021). Risk of false pharmaceutical equivalence (non-equivalence) decisions due to measurement uncertainty. Journal of Pharmaceutical and Biomedical Analysis, 204, 1-9 art. 114269. doi:10.1016/j.jpba.2021.114269
NLM
Bertanha ML de G, Lourenço FR. Risk of false pharmaceutical equivalence (non-equivalence) decisions due to measurement uncertainty [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2021 ; 204 1-9 art. 114269.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.jpba.2021.114269
Vancouver
Bertanha ML de G, Lourenço FR. Risk of false pharmaceutical equivalence (non-equivalence) decisions due to measurement uncertainty [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2021 ; 204 1-9 art. 114269.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.jpba.2021.114269
Artigo de periodico
Intercambiabilidad de medicamentos en el Perú: panorama actual y perspectivas futuras (2021)
Chauca, Enma Perez ; Ferraz, Humberto Gomes
Fonte: Revista Peruana de Medicina Experimental y Salud Pública. Unidade: FCF
Assuntos: BIOEQUIVALÊNCIA, MEDICAMENTO GENÉRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAUCA, Enma Perez e FERRAZ, Humberto Gomes. Intercambiabilidad de medicamentos en el Perú: panorama actual y perspectivas futuras. Revista Peruana de Medicina Experimental y Salud Pública, v. 38, n. 2, p. 337-44, 2021Tradução . . Disponível em: https://doi.org/10.17843/rpmesp.2021.382.7322. Acesso em: 13 nov. 2024.
APA
Chauca, E. P., & Ferraz, H. G. (2021). Intercambiabilidad de medicamentos en el Perú: panorama actual y perspectivas futuras. Revista Peruana de Medicina Experimental y Salud Pública, 38( 2), 337-44. doi:10.17843/rpmesp.2021.382.7322
NLM
Chauca EP, Ferraz HG. Intercambiabilidad de medicamentos en el Perú: panorama actual y perspectivas futuras [Internet]. Revista Peruana de Medicina Experimental y Salud Pública. 2021 ; 38( 2): 337-44.[citado 2024 nov. 13 ] Available from: https://doi.org/10.17843/rpmesp.2021.382.7322
Vancouver
Chauca EP, Ferraz HG. Intercambiabilidad de medicamentos en el Perú: panorama actual y perspectivas futuras [Internet]. Revista Peruana de Medicina Experimental y Salud Pública. 2021 ; 38( 2): 337-44.[citado 2024 nov. 13 ] Available from: https://doi.org/10.17843/rpmesp.2021.382.7322
Artigo de periodico
In silico prediction of plasma concentrations of Fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation (2019)
Duque, Marcelo Dutra; Silva, Daniela Amaral; Issa, Michele Georges ; Porta, Valentina ; Löbenberg, Raimar ; Ferraz, Humberto Gomes
Fonte: Pharmaceutics. Unidade: FCF
Assuntos: BIOEQUIVALÊNCIA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUQUE, Marcelo Dutra et al. In silico prediction of plasma concentrations of Fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation. Pharmaceutics, v. 11, p. 1-12 art. 215, 2019Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics11050215. Acesso em: 13 nov. 2024.
APA
Duque, M. D., Silva, D. A., Issa, M. G., Porta, V., Löbenberg, R., & Ferraz, H. G. (2019). In silico prediction of plasma concentrations of Fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation. Pharmaceutics, 11, 1-12 art. 215. doi:10.3390/pharmaceutics11050215
NLM
Duque MD, Silva DA, Issa MG, Porta V, Löbenberg R, Ferraz HG. In silico prediction of plasma concentrations of Fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation [Internet]. Pharmaceutics. 2019 ; 11 1-12 art. 215.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3390/pharmaceutics11050215
Vancouver
Duque MD, Silva DA, Issa MG, Porta V, Löbenberg R, Ferraz HG. In silico prediction of plasma concentrations of Fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation [Internet]. Pharmaceutics. 2019 ; 11 1-12 art. 215.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3390/pharmaceutics11050215
Artigo de periodico
In vitro therapeutic equivalence of cephalexin 500 mg tablets commercialized in Brazil (2018)
Ghisleni, Daniela Dal Molim ; Kikuchi, Irene Satiko ; Saviano, Alessandro Morais; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar; Araujo, Gabriel Lima Barros de ; Pinto, Terezinha de Jesus Andreoli ; Lourenço, Felipe Rebello
Fonte: Latin American Journal of Pharmacy. Unidade: FCF
Assuntos: BIOEQUIVALÊNCIA, MEDICAMENTO GENÉRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GHISLENI, Daniela Dal Molim et al. In vitro therapeutic equivalence of cephalexin 500 mg tablets commercialized in Brazil. Latin American Journal of Pharmacy, v. 37, n. 1, p. 7-11, 2018Tradução . . Acesso em: 13 nov. 2024.
APA
Ghisleni, D. D. M., Kikuchi, I. S., Saviano, A. M., Bou-Chacra, N. A., Löbenberg, R., Araujo, G. L. B. de, et al. (2018). In vitro therapeutic equivalence of cephalexin 500 mg tablets commercialized in Brazil. Latin American Journal of Pharmacy, 37( 1), 7-11.
NLM
Ghisleni DDM, Kikuchi IS, Saviano AM, Bou-Chacra NA, Löbenberg R, Araujo GLB de, Pinto T de JA, Lourenço FR. In vitro therapeutic equivalence of cephalexin 500 mg tablets commercialized in Brazil. Latin American Journal of Pharmacy. 2018 ; 37( 1): 7-11.[citado 2024 nov. 13 ]
Vancouver
Ghisleni DDM, Kikuchi IS, Saviano AM, Bou-Chacra NA, Löbenberg R, Araujo GLB de, Pinto T de JA, Lourenço FR. In vitro therapeutic equivalence of cephalexin 500 mg tablets commercialized in Brazil. Latin American Journal of Pharmacy. 2018 ; 37( 1): 7-11.[citado 2024 nov. 13 ]
Parte de monografia/livro
Bioequivalence requirements in various global jurisdictions (2017)
Cristofoletti, Rodrigo; Marques, Margareth Rita de Cassia; Storpirtis, Silvia
Fonte: Bioequivalence Requirements in Various Global Jurisdictions. Unidade: FCF
Assunto: BIOEQUIVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRISTOFOLETTI, Rodrigo e MARQUES, Margareth Rita de Cassia e STORPIRTIS, Silvia. Bioequivalence requirements in various global jurisdictions. Bioequivalence Requirements in Various Global Jurisdictions. Tradução . Heidelberg: Springer, 2017. . . Acesso em: 13 nov. 2024.
APA
Cristofoletti, R., Marques, M. R. de C., & Storpirtis, S. (2017). Bioequivalence requirements in various global jurisdictions. In Bioequivalence Requirements in Various Global Jurisdictions. Heidelberg: Springer.
NLM
Cristofoletti R, Marques MR de C, Storpirtis S. Bioequivalence requirements in various global jurisdictions. In: Bioequivalence Requirements in Various Global Jurisdictions. Heidelberg: Springer; 2017. [citado 2024 nov. 13 ]
Vancouver
Cristofoletti R, Marques MR de C, Storpirtis S. Bioequivalence requirements in various global jurisdictions. In: Bioequivalence Requirements in Various Global Jurisdictions. Heidelberg: Springer; 2017. [citado 2024 nov. 13 ]
Artigo de periodico
Effect of different sampling schedules on results of bioavailability and bioequivalence studies: evaluation by means of Monte Carlo simulations (2017)
Kano, Eunice Kazue; Chiann, Chang ; Fukuda, Kazuo; Porta, Valentina
Fonte: Drug Research. Unidades: FCF, IME
Assuntos: FARMACOCINÉTICA, BIODISPONIBILIDADE, BIOEQUIVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KANO, Eunice Kazue et al. Effect of different sampling schedules on results of bioavailability and bioequivalence studies: evaluation by means of Monte Carlo simulations. Drug Research, v. 67, n. 8, p. 451-457, 2017Tradução . . Disponível em: https://doi.org/10.1055/s-0043-105797. Acesso em: 13 nov. 2024.
APA
Kano, E. K., Chiann, C., Fukuda, K., & Porta, V. (2017). Effect of different sampling schedules on results of bioavailability and bioequivalence studies: evaluation by means of Monte Carlo simulations. Drug Research, 67( 8), 451-457. doi:10.1055/s-0043-105797
NLM
Kano EK, Chiann C, Fukuda K, Porta V. Effect of different sampling schedules on results of bioavailability and bioequivalence studies: evaluation by means of Monte Carlo simulations [Internet]. Drug Research. 2017 ; 67( 8): 451-457.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1055/s-0043-105797
Vancouver
Kano EK, Chiann C, Fukuda K, Porta V. Effect of different sampling schedules on results of bioavailability and bioequivalence studies: evaluation by means of Monte Carlo simulations [Internet]. Drug Research. 2017 ; 67( 8): 451-457.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1055/s-0043-105797
Artigo de periodico
Measuring uncertainty using different approaches: a case study for acetaminophen quantification (2016)
Francisco, Fabiane Lacerda; Saviano, Alessandro Morais; Lourenço, Felipe Rebello
Fonte: Journal of AOAC International. Unidade: FCF
Assuntos: BIOEQUIVALÊNCIA, PARACETAMOL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRANCISCO, Fabiane Lacerda e SAVIANO, Alessandro Morais e LOURENÇO, Felipe Rebello. Measuring uncertainty using different approaches: a case study for acetaminophen quantification. Journal of AOAC International, v. 99, n. 3, p. 612-617, 2016Tradução . . Disponível em: https://doi.org/10.5740/jaoacint.15-0199. Acesso em: 13 nov. 2024.
APA
Francisco, F. L., Saviano, A. M., & Lourenço, F. R. (2016). Measuring uncertainty using different approaches: a case study for acetaminophen quantification. Journal of AOAC International, 99( 3), 612-617. doi:10.5740/jaoacint.15-0199
NLM
Francisco FL, Saviano AM, Lourenço FR. Measuring uncertainty using different approaches: a case study for acetaminophen quantification [Internet]. Journal of AOAC International. 2016 ; 99( 3): 612-617.[citado 2024 nov. 13 ] Available from: https://doi.org/10.5740/jaoacint.15-0199
Vancouver
Francisco FL, Saviano AM, Lourenço FR. Measuring uncertainty using different approaches: a case study for acetaminophen quantification [Internet]. Journal of AOAC International. 2016 ; 99( 3): 612-617.[citado 2024 nov. 13 ] Available from: https://doi.org/10.5740/jaoacint.15-0199
Artigo de periodico
Average bioequivalence of single 500 mg doses of two oral formulations of levofloxacin: a randomized, open-label, two-period crossover study in healthy adult Brazilian volunteers (2015)
Kano, Eunice Kazue; Koono, Eunice Emiko Mori; Schramm, Simone Grigoleto; Serra, Cristina Helena dos Reis ; Abib Junior, Eduardo; Pereira, Renata; Freitas, Marcia Sayuri Takamatsu; Iecco, Maria Cristina; Porta, Valentina
Fonte: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF
Assuntos: BIOEQUIVALÊNCIA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KANO, Eunice Kazue et al. Average bioequivalence of single 500 mg doses of two oral formulations of levofloxacin: a randomized, open-label, two-period crossover study in healthy adult Brazilian volunteers. Brazilian Journal of Pharmaceutical Sciences, v. 51, n. 1, p. 503-511, 2015Tradução . . Disponível em: https://doi.org/10.1590/S1984-82502015000100020. Acesso em: 13 nov. 2024.
APA
Kano, E. K., Koono, E. E. M., Schramm, S. G., Serra, C. H. dos R., Abib Junior, E., Pereira, R., et al. (2015). Average bioequivalence of single 500 mg doses of two oral formulations of levofloxacin: a randomized, open-label, two-period crossover study in healthy adult Brazilian volunteers. Brazilian Journal of Pharmaceutical Sciences, 51( 1), 503-511. doi:10.1590/S1984-82502015000100020
NLM
Kano EK, Koono EEM, Schramm SG, Serra CH dos R, Abib Junior E, Pereira R, Freitas MST, Iecco MC, Porta V. Average bioequivalence of single 500 mg doses of two oral formulations of levofloxacin: a randomized, open-label, two-period crossover study in healthy adult Brazilian volunteers [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51( 1): 503-511.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1590/S1984-82502015000100020
Vancouver
Kano EK, Koono EEM, Schramm SG, Serra CH dos R, Abib Junior E, Pereira R, Freitas MST, Iecco MC, Porta V. Average bioequivalence of single 500 mg doses of two oral formulations of levofloxacin: a randomized, open-label, two-period crossover study in healthy adult Brazilian volunteers [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51( 1): 503-511.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1590/S1984-82502015000100020
Artigo de periodico
In Vitro therapeutic equivalence of acetaminophen oral solution in dripper bottles (2015)
Moreira, Camila S; Lourenço, Felipe Rebello
Fonte: Latin American Journal of Pharmacy. Unidade: FCF
Assuntos: ANÁLISE MULTIVARIADA, BIOEQUIVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Camila S e LOURENÇO, Felipe Rebello. In Vitro therapeutic equivalence of acetaminophen oral solution in dripper bottles. Latin American Journal of Pharmacy, v. 34, n. 1, p. 78-85, 2015Tradução . . Acesso em: 13 nov. 2024.
APA
Moreira, C. S., & Lourenço, F. R. (2015). In Vitro therapeutic equivalence of acetaminophen oral solution in dripper bottles. Latin American Journal of Pharmacy, 34( 1), 78-85.
NLM
Moreira CS, Lourenço FR. In Vitro therapeutic equivalence of acetaminophen oral solution in dripper bottles. Latin American Journal of Pharmacy. 2015 ; 34( 1): 78-85.[citado 2024 nov. 13 ]
Vancouver
Moreira CS, Lourenço FR. In Vitro therapeutic equivalence of acetaminophen oral solution in dripper bottles. Latin American Journal of Pharmacy. 2015 ; 34( 1): 78-85.[citado 2024 nov. 13 ]
Artigo de periodico
Dissolution efficiency and bioequivalence study using urine data from healthy volunteers: a comparison between two tablet formulations of cephalexin (2015)
Serra, Cristina Helena dos Reis ; Chang, Kyung Hee; Dezani, Thaisa Marinho; Porta, Valentina ; Storpirtis, Silvia
Fonte: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF
Assuntos: BIOEQUIVALÊNCIA, COMPRIMIDOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SERRA, Cristina Helena dos Reis et al. Dissolution efficiency and bioequivalence study using urine data from healthy volunteers: a comparison between two tablet formulations of cephalexin. Brazilian Journal of Pharmaceutical Sciences, v. 51, n. 2, p. 383-392, 2015Tradução . . Disponível em: https://doi.org/10.1590/s1984-82502015000200016. Acesso em: 13 nov. 2024.
APA
Serra, C. H. dos R., Chang, K. H., Dezani, T. M., Porta, V., & Storpirtis, S. (2015). Dissolution efficiency and bioequivalence study using urine data from healthy volunteers: a comparison between two tablet formulations of cephalexin. Brazilian Journal of Pharmaceutical Sciences, 51( 2), 383-392. doi:10.1590/s1984-82502015000200016
NLM
Serra CH dos R, Chang KH, Dezani TM, Porta V, Storpirtis S. Dissolution efficiency and bioequivalence study using urine data from healthy volunteers: a comparison between two tablet formulations of cephalexin [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51( 2): 383-392.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1590/s1984-82502015000200016
Vancouver
Serra CH dos R, Chang KH, Dezani TM, Porta V, Storpirtis S. Dissolution efficiency and bioequivalence study using urine data from healthy volunteers: a comparison between two tablet formulations of cephalexin [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51( 2): 383-392.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1590/s1984-82502015000200016
Artigo de periodico
Challenges and opportunities to use biowaivers to compare generics in China (2014)
Zuo, Jieyu; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar
Fonte: AAPS PharmSciTech. Unidade: FCF
Assuntos: BIOEQUIVALÊNCIA, MEDICAMENTO GENÉRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZUO, Jieyu e BOU-CHACRA, Nadia Araci e LÖBENBERG, Raimar. Challenges and opportunities to use biowaivers to compare generics in China. AAPS PharmSciTech, v. 15, n. 5, p. 1070-1075, 2014Tradução . . Disponível em: https://doi.org/10.1208/s12249-014-0133-8. Acesso em: 13 nov. 2024.
APA
Zuo, J., Bou-Chacra, N. A., & Löbenberg, R. (2014). Challenges and opportunities to use biowaivers to compare generics in China. AAPS PharmSciTech, 15( 5), 1070-1075. doi:10.1208/s12249-014-0133-8
NLM
Zuo J, Bou-Chacra NA, Löbenberg R. Challenges and opportunities to use biowaivers to compare generics in China [Internet]. AAPS PharmSciTech. 2014 ; 15( 5): 1070-1075.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1208/s12249-014-0133-8
Vancouver
Zuo J, Bou-Chacra NA, Löbenberg R. Challenges and opportunities to use biowaivers to compare generics in China [Internet]. AAPS PharmSciTech. 2014 ; 15( 5): 1070-1075.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1208/s12249-014-0133-8
Artigo de periodico
A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies (2013)
Cristofoletti, Rodrigo; Chiann, Chang ; Dressman, Jennifer B; Storpirtis, Silvia
Fonte: Journal of Pharmaceutical Sciences. Unidades: IME, FCF
Assuntos: BIOEQUIVALÊNCIA, SOLUBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRISTOFOLETTI, Rodrigo et al. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies. Journal of Pharmaceutical Sciences, v. 102, n. 9, p. 3136-3144, 2013Tradução . . Disponível em: https://doi.org/10.1002/jps.23515. Acesso em: 13 nov. 2024.
APA
Cristofoletti, R., Chiann, C., Dressman, J. B., & Storpirtis, S. (2013). A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies. Journal of Pharmaceutical Sciences, 102( 9), 3136-3144. doi:10.1002/jps.23515
NLM
Cristofoletti R, Chiann C, Dressman JB, Storpirtis S. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies [Internet]. Journal of Pharmaceutical Sciences. 2013 ; 102( 9): 3136-3144.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/jps.23515
Vancouver
Cristofoletti R, Chiann C, Dressman JB, Storpirtis S. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies [Internet]. Journal of Pharmaceutical Sciences. 2013 ; 102( 9): 3136-3144.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/jps.23515
Artigo de periodico
Biowaiver monographs for immediate-release solid oral dosage forms: Zidovudine (azidothymidine) (2013)
Soares, Kelen C. C; Rediguieri, Camila Fracalossi; Souza, Jacqueline de ; Serra, Cristina Helena dos Reis ; Abrahamsson, Bertil; Groot, D. W; Kopp, Sabine; Langguth, Peter; Polli, James E; Shah, Vinod P; Dressman, Jennifer
Fonte: Journal of Pharmaceutical Sciences. Unidade: FCF
Assuntos: ZIDOVUDINA, SOLUBILIDADE, BIODISPONIBILIDADE, BIOEQUIVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, Kelen C. C et al. Biowaiver monographs for immediate-release solid oral dosage forms: Zidovudine (azidothymidine). Journal of Pharmaceutical Sciences, v. 102, n. 8, p. 2409-2423, 2013Tradução . . Disponível em: https://doi.org/10.1002/jps.23624. Acesso em: 13 nov. 2024.
APA
Soares, K. C. C., Rediguieri, C. F., Souza, J. de, Serra, C. H. dos R., Abrahamsson, B., Groot, D. W., et al. (2013). Biowaiver monographs for immediate-release solid oral dosage forms: Zidovudine (azidothymidine). Journal of Pharmaceutical Sciences, 102( 8), 2409-2423. doi:10.1002/jps.23624
NLM
Soares KCC, Rediguieri CF, Souza J de, Serra CH dos R, Abrahamsson B, Groot DW, Kopp S, Langguth P, Polli JE, Shah VP, Dressman J. Biowaiver monographs for immediate-release solid oral dosage forms: Zidovudine (azidothymidine) [Internet]. Journal of Pharmaceutical Sciences. 2013 ; 102( 8): 2409-2423.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/jps.23624
Vancouver
Soares KCC, Rediguieri CF, Souza J de, Serra CH dos R, Abrahamsson B, Groot DW, Kopp S, Langguth P, Polli JE, Shah VP, Dressman J. Biowaiver monographs for immediate-release solid oral dosage forms: Zidovudine (azidothymidine) [Internet]. Journal of Pharmaceutical Sciences. 2013 ; 102( 8): 2409-2423.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/jps.23624
Artigo de periodico
Pharmacokinetics and bioequivalence evaluation of cyclobenzaprine tablets (2013)
Brioschi, Tatiane Maria de Lima Souza; Schramm, Simone Grigoleto; Kano, Eunice Kazue; Koono, Eunice Emiko Mori; Ching, Ting Hui; Serra, Cristina Helena dos Reis ; Porta, Valentina
Fonte: BioMed Research International. Unidade: FCF
Assuntos: BIOEQUIVALÊNCIA, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRIOSCHI, Tatiane Maria de Lima Souza et al. Pharmacokinetics and bioequivalence evaluation of cyclobenzaprine tablets. BioMed Research International, v. 2013, p. 1-6, 2013Tradução . . Disponível em: https://doi.org/10.1155/2013/281392. Acesso em: 13 nov. 2024.
APA
Brioschi, T. M. de L. S., Schramm, S. G., Kano, E. K., Koono, E. E. M., Ching, T. H., Serra, C. H. dos R., & Porta, V. (2013). Pharmacokinetics and bioequivalence evaluation of cyclobenzaprine tablets. BioMed Research International, 2013, 1-6. doi:10.1155/2013/281392
NLM
Brioschi TM de LS, Schramm SG, Kano EK, Koono EEM, Ching TH, Serra CH dos R, Porta V. Pharmacokinetics and bioequivalence evaluation of cyclobenzaprine tablets [Internet]. BioMed Research International. 2013 ; 2013 1-6.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1155/2013/281392
Vancouver
Brioschi TM de LS, Schramm SG, Kano EK, Koono EEM, Ching TH, Serra CH dos R, Porta V. Pharmacokinetics and bioequivalence evaluation of cyclobenzaprine tablets [Internet]. BioMed Research International. 2013 ; 2013 1-6.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1155/2013/281392

Unidades USP

ReP

Filtros

Tipo de material

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Editora

Nome do evento

País de publicação

Grupo de pesquisa

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos